Jason N. Butler's Stock Ratings

Citizens Analyst

Jason N. Butler is an analyst at Citizens. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025

Updated: Dec 15, 2025

Overall Average Return

10.4%

Smart Score

61.4%

Overall Average Return Percentile

59th

Number of Ratings

11
Buy NowGet Alert
11/25/2025ACHVBuy Now
Achieve Life Sciences
$4.47325.06% → $19Initiates → Market OutperformGet Alert
11/07/2025RAPPBuy Now
Rapport Therapeutics
$29.60170.27%$77 → $80MaintainsMarket OutperformGet Alert
10/29/2025WULFBuy Now
TeraWulf
$12.4976.14%$18 → $22MaintainsMarket OutperformGet Alert
10/29/2025RZLTBuy Now
Rezolute
$1.58975.95%$9 → $17MaintainsMarket OutperformGet Alert
09/25/2025ABVXBuy Now
Abivax
$118.33-3.66%$95 → $114MaintainsMarket OutperformGet Alert
09/09/2025CRMDBuy Now
Cormedix
$11.4492.38%$22 → $22ReiteratesMarket Outperform → Market OutperformGet Alert
09/02/2025CYTKBuy Now
Cytokinetics
$62.1625.48%$78 → $78ReiteratesMarket Outperform → Market OutperformGet Alert
08/19/2025PGENBuy Now
Precigen
$3.81109.97%$6 → $8MaintainsMarket OutperformGet Alert
08/13/2025ZVRABuy Now
Zevra Therapeutics
$8.15120.83%$19 → $18MaintainsMarket OutperformGet Alert
08/07/2025ACADBuy Now
ACADIA Pharmaceuticals
$27.4938.23%$37 → $38MaintainsMarket OutperformGet Alert
08/06/2025HALOBuy Now
Halozyme Therapeutics
$63.4143.51%$78 → $91MaintainsMarket OutperformGet Alert